The α 1L-adrenoceptor is an alternative phenotype of the α 1A-adrenoceptor

British Journal of Pharmacology

Volumn 155, Issue 1, 2008, Pages 1-3

  Nelson, C P ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

adrenoceptor; Cell background; G protein coupled receptor; Knockout mice; Phenotypic pharmacology

Indexed keywords

5 METHYLURAPIDIL; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1L ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; BETA 4 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; G PROTEIN COUPLED RECEPTOR; GENE PRODUCT; INOSITOL PHOSPHATE; NORADRENALIN; PRAZOSIN; RADIOLIGAND; TAMSULOSIN; TRITIUM; UNCLASSIFIED DRUG; ADRENERGIC RECEPTOR ALPHA(1A); ADRENERGIC RECEPTOR ALPHA(1L); ALPHA 1 ADRENERGIC RECEPTOR;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; CHO CELL; GENE EXPRESSION; HUMAN; KNOCKOUT MOUSE; LIGAND BINDING; MALE; MOUSE; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RAT; RECEPTOR GENE; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; ANIMAL; DRUG EFFECT; GENETICS; GENOTYPE; INNERVATION; METABOLISM; MOUSE MUTANT; MUSCLE CONTRACTION; PROSTATE;

ANIMALS; GENOTYPE; MALE; MICE; MICE, KNOCKOUT; MUSCLE CONTRACTION; NOREPINEPHRINE; PHENOTYPE; PROSTATE; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 84858998882     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.264     Document Type: Note

References (12)

1. Ford AP, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD et al. (1997). Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol 121: 1127-1135.
2. Granneman JG (2001). The putative beta4-adrenergic receptor is a novel state of the beta1-adrenergic receptor. Am J Physiol Endocrinol Metab 280: E199-E202.
3. Gray KT, Ventura S (2006). Alpha1L-adrenoceptors mediate contractions of the isolated mouse prostate. Eur J Pharmacol 540: 155-161.
4. 1L-adrenoceptor-mediated response in isolated preparations of the mouse prostate. Br J Pharmacol 155: 103-109 (this issue).
5. Guimaraes S, Moura D (2001). Vascular adrenoceptors: an update. Pharmacol Rev 53: 319-356.
6. Hiraoka Y, Ohmura T, Oshita M, Watanabe Y, Morikawa K, Nagata O et al. (1999). Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate. Eur J Pharmacol 366: 119-126.
7. Kaumann AJ (1989). Is there a third heart beta-adrenoceptor? Trends Pharmacol Sci 10: 316-320.
8. Milani S, Djavan B (2005). Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on alpha-adrenoceptor antagonists. BJU Int 95 (Suppl 4): 29-36.
9. 1A-adrenoceptors. Br J Pharmacol 153: 1485-1494.
10. Morishima S, Tanaka T, Yamamoto H, Suzuki F, Akino H, Yokoyama O et al. (2007). Identification of alpha-1L and alpha-1A adrenoceptors in human prostate by tissue segment binding. J Urol 177: 377-381.
11. Nelson CP, Challiss RA (2007). 'Phenotypic' pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology. Biochem Pharmacol 73: 737-751.
12. Rokosh DG, Simpson PC (2002). Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA 99: 9474-9479